ADAPT

(redirected from Alzheimer's Disease Anti-Inflammatory Prevention Trial)
Also found in: Dictionary, Thesaurus, Medical.

ADAPT

(language)
A subset of APT.

[Sammet 1969, p. 606].

adapt

To make suitable for a particular purpose or new requirements or conditions, by means of modifications or changes.
References in periodicals archive ?
In order to find additional biomarkers a commitment to fund more longitudinal studies such as Alzheimer's Disease Neuroimaging, Alzheimer's Disease Anti-inflammatory Prevention Trial and Gingko in Evaluation of Memory is needed.
Sponsored by the National Institute on Aging, part of the National Institutes of Health (N.I.H.), the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) has been evaluating the efficacy and safety of NSAIDs for the primary prevention of dementia.
Soon thereafter, research investigators suspended the Alzheimer's Disease Anti-Inflammatory Prevention Trial after preliminary data indicated a 50% increased risk for cardiovascular events in participants assigned to take 220 mg twice daily of the nonselective NSAID naproxen (Aleve, Naprosyn).

Full browser ?